Table 4.
TIL phenotypes | Subgroup | No of studies | I2 (P) | HR (95% CI) | P |
---|---|---|---|---|---|
CD3+ TILs | CM | 3 | 51% (0.130) | 0.93 (0.27–3.15) | 0.906 |
UM | 1 | 5.5 (N/A- N/A) | 0.03 | ||
M | 4 | 28.4% (0.241) | 0.55 (0.4–0.77) | <0.001 | |
CD4+ TILs | CM | 1 | 0.22 (0.09–0.55) | 0.001 | |
UM | 1 | 0.80 (0.50–1.27) | 0.346 | ||
M | 4 | 55.6% (0.080) | 0.60 (0.37–0.97) | 0.039 | |
CD8+ TILs | CM | 2 | 0.0% (0.352) | 0.38 (0.19–0.75) | 0.005 |
M | 5 | 50.4% (0.089) | 0.53 (0.37–0.75) | <0.001 | |
FOXP3+ TILs | CM | 4 | 0% (0.785) | 0.58 (0.36–0.95) | 0.032 |
UM | 1 | 1.14 (0.68–1.91) | 0.617 | ||
M | 4 | 47.6% (0.126) | 0.45 (0.28–0.73) | 0.001 | |
CD20+ TILs | CM | 1 | 0.42 (0.06–2.91) | 0.380 | |
M | 2 | 0% (0.456) | 0.49 (0.34–0.72) | <0.001 |